Filter Results:
(990)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
- 19 Aug 2024
- News
Quantum Leap
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Dan Morrell: Hi, this is Dan Morrell, host of Skydeck. Quantum computing has long been talked about as one of the next big things—the kind of technology, like AI, that will change everything. But to our... View Details
- 28 Oct 2014
- First Look
First Look: October 28
disruptive to its drug development efforts and delay new drugs coming to market. UK politicians expressed concerns over downsizing and job losses in the economically important pharmaceutical sector. The case... View Details
Keywords: Carmen Nobel
- 09 Mar 2020
- Research & Ideas
Warring Algorithms Could Be Driving Up Consumer Prices
being in second place, it’s a pretty good place to be.” Consumers end up paying more To study how pricing algorithms affect competition, MacKay and Brown collected detailed pricing data from five large, multicategory retailers selling the same over-the-counter allergy... View Details
- 01 Jun 2008
- News
A Binary Formula
career in drug development and biotech companies, leading both R&D and business functions. She teaches the MBA elective Inventing Breakthroughs and Commercializing Science and an Executive Education offering Leading Science-Based... View Details
- 03 Mar 2009
- First Look
First Look: March 3, 2009
Public Interest: Roche & Tamiflu Harvard Business School Case 609-061 The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu.... View Details
Keywords: Martha Lagace
- 23 Aug 2010
- Research & Ideas
The Drive to Acquire’s Impact on Globalization
inherently abusive; the citizens of the developed country are winners and the citizens of the undeveloped country may be getting a better or cheaper product. But when regulation is weak or nonexistent, this system can lend itself to severe abuse, as in the sale of fake... View Details
Keywords: by Paul R. Lawrence
- 01 Jun 2009
- News
Cynthia Carroll
we provide free antiretroviral drugs to our 3,000 HIV- positive employees. In South America, we have multimillion-dollar projects to improve goat and cattle breeds, boost honey production, and diversify agricultural output. We work hard... View Details
- 27 Nov 2017
- Research & Ideas
Beware the Lasting Impression of a 'Temporary' Selfie
a prop, or exhibited nudity, drinking, or drug use. As to the impact on observers of the posts, the temporary-sharers were characterized as having worse judgment than those who shared in permanent mediums. That belief was underscored... View Details
Keywords: by Rachel Layne
- 01 Sep 2004
- News
A Market-Based Prescription
change? Congress has already passed a piece of legislation that is tremendously important to the consumer-driven movement. Health savings accounts, established as part of the Medicare prescription drug bill in 2003, will allow the... View Details
- Web
1.19 Immersive Field Courses (IFC) | MBA
right to modify the course or deny a student’s choice of location(s) for coursework participation, whichever is the least-restrictive reasonable alternative. Drug & Alcohol Policy The HBS Drug & Alcohol... View Details
- 21 Jul 2015
- First Look
First Look: July 21, 2015
new drug markets. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=49384 Cases & Course Materials Harvard Business School Case 715-438 The Transformation of NCR During his tenure as CEO since 2005, Bill Nuti... View Details
Keywords: Sean Silverthorne
- 08 Jun 2010
- First Look
First Look: June 8
case:http://cb.hbsp.harvard.edu/cb/product/810123-PDF-ENG Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Karim R. Lakhani and Paul R. CarlileHarvard Business School Case 610-074 This case presents the Myelin... View Details
Keywords: Martha Lagace
- 09 Sep 2014
- First Look
First Look: September 9
patient. Schrader and his colleagues had to decide on which vaccines to focus and whether and how to target the drug companies that manufactured the vaccines or the quasi-government organizations (such as UNICEF and PAHO) and... View Details
Keywords: Sean Silverthorne
- 01 Mar 2019
- News
The Blue-Green Revolution
make food in the stuff,” he says. Capitalizing on its burgeoning algal expertise, SGI has already bred one strain that can make highquality protein and healthful fatty acids, and it hopes to coax others into producing biological drugs... View Details
- 17 Oct 2012
- Research & Ideas
America Needs a Manufacturing Renaissance
sciences that laid the institutional foundations for innovations in semiconductors, high-speed computers, computer graphics, broadband communications, mobile telephony, the Internet, and modern genomics-based methods of drug discovery.... View Details
- 02 Apr 2014
- News
Disrupting the Criminal Supply Chain
her dual law and business degrees to fight some of the world's most disturbing criminals. Since 2011, Brochu, 42, has been the United Nations Office on Drugs and Crime's Expert on Child Exploitation and Human Trafficking, a position she... View Details
- Web
1.18 Field Global Capstone | MBA
choice of location(s) for coursework participation, whichever is the least-restrictive reasonable alternative. Drug & Alcohol Policy The HBS Drug & Alcohol Policy states expectations for responsible alcohol... View Details
- 27 Mar 2012
- First Look
First Look: March 27
services will become its key competitive advantage in the decade to come. This case traces the evolution of the CRO sector from a small, secondary cluster of firms into a major player with essential capabilities for global drug... View Details
Keywords: Carmen Nobel
- 30 Oct 2007
- First Look
First Look: October 30, 2007
Changing Context of Pharmaceutical Risk Mitigation Author:Arthur A. Daemmrich Periodical:Pharmacy in History 49, no. 2 (2007): 61-75 Abstract In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side... View Details
Keywords: Sean Silverthorne
- 22 Aug 2006
- First Look
First Look: August 22, 2006
805-067 Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to... View Details
Keywords: Martha Lagace